Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy –
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy –